What does Perseus Proteomics Inc. do?
Perseus Proteomics Inc., a drug discovery biotech venture company, develops and sells antibody-based pharmaceuticals and research reagents for cancer and other diseases in Japan. The company is involved in the antibody discovery activities; and antibody research support activities comprising hybridoma antibody…
What is Perseus Proteomics Inc.'s P/E and P/B ratio?
Perseus Proteomics Inc. has a P/E ratio of -3.0 and a P/B ratio of 2.17.
What is Perseus Proteomics Inc.'s debt-to-equity ratio?
Perseus Proteomics Inc. has a debt-to-equity ratio of 0.00.
How much does Perseus Proteomics Inc. owe compared with what it owns?
Perseus Proteomics Inc. owes ¥0.27 for every ¥1 it owns (balance sheet Jun 2026), which is low.
What is Perseus Proteomics Inc.'s Positivity rank?
Perseus Proteomics Inc. is ranked #7,239 of 10,750 companies globally and #3,189 of 3,683 in Japan on PositoAI, with a Positivity Score of 20,206.
Does Perseus Proteomics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Perseus Proteomics Inc..
Where can I read the latest news about Perseus Proteomics Inc.?
Recent headlines about Perseus Proteomics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Perseus Proteomics Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Perseus Proteomics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.